In this issue:
Leukaemia selection
• Pretransplant imatinib in BCR–ABL-positive ALL
• Reduced mortality after allogeneic transplantation
• MRC AML15: addition of gemtuzumab ozogamicin in AML
• Imaging techniques for advanced CLL follow-up
Lymphoma selection
• Escalation to BEACOPP in PET-positive HL after two ABVD courses
• Bone marrow involvement and outcomes in R-CHOP-treated DLBCL
• R-CHOP + bortezomib for untreated DLBCL and MCL
• R-CHOP ± gemcitabine in untreated aggressive NHL
• Immunohistochemical algorithms for predicting cell of origin and survival in DLBCL
• Cladribine + rituximab in indolent B-cell NHL
Please login below to download this issue (PDF)